Literature DB >> 23830927

The impact of single-nucleotide polymorphisms (SNPs) in OGG1 and XPC on the age at onset of Huntington disease.

Frédérique Berger1, Laurence Vaslin, Lisa Belin, Bernard Asselain, Sylvie Forlani, Sandrine Humbert, Alexandra Durr, Janet Hall.   

Abstract

The age at onset of Huntington disease (HD) shows a strong, negative correlation with the number of CAG repeats within the huntingtin (HTT) gene. However, this does not account for all the inter-individual variability seen among patients. In order to assess whether single-nucleotide polymorphisms (SNPs) in the OGG1 and XPC genes, both implicated in responses to oxidative stress, are associated with the age of onset of HD, 9 SNPs have been genotyped in 299 individuals with HD and 582 controls. After correction for multiple testing, two OGG1/XPC haplotypes were found to be associated with younger age at onset independently of the number of CAG repeats within the HTT gene. Both haplotypes contain XPC coding variants that would be expected to impact on protein function and/or variants in the 3'UTR that could result in altered protein levels via allele-specific mIR binding. One haplotype also contains the OGG1-326Cys (rs1052133) allele that has been associated with a lower 8-oxoG repair activity and is particularly sensitive to the cellular redox status. These results highlight the potential role of oxidative stress in determining the age at onset of HD.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Age at onset; Huntington disease; OGG1; XPC

Mesh:

Substances:

Year:  2013        PMID: 23830927     DOI: 10.1016/j.mrgentox.2013.04.020

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  8 in total

Review 1.  Oxidative and energy metabolism as potential clues for clinical heterogeneity in nucleotide excision repair disorders.

Authors:  Mohsen Hosseini; Khaled Ezzedine; Alain Taieb; Hamid R Rezvani
Journal:  J Invest Dermatol       Date:  2014-10-09       Impact factor: 8.551

Review 2.  Prospects for neuroprotective therapies in prodromal Huntington's disease.

Authors:  Abhishek Chandra; Ashu Johri; M Flint Beal
Journal:  Mov Disord       Date:  2014-02-26       Impact factor: 10.338

3.  Lack of association between XPC Lys939Gln polymorphism and prostate cancer risk: an updated meta-analysis based on 3039 cases and 3253 controls.

Authors:  Haoran Wu; Zhong Lv; Xugang Wang; Liang Zhang; Naixin Mo
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  Senile cataract and genetic polymorphisms of APE1, XRCC1 and OGG1.

Authors:  Chen Wang; Qiaohong Lai; Shu Zhang; Jun Hu
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

5.  Asbestos-induced pulmonary fibrosis is augmented in 8-oxoguanine DNA glycosylase knockout mice.

Authors:  Paul Cheresh; Luisa Morales-Nebreda; Seok-Jo Kim; Anjana Yeldandi; David B Williams; Yuan Cheng; Gökhan M Mutlu; G R Scott Budinger; Karen Ridge; Paul T Schumacker; Vilhelm A Bohr; David W Kamp
Journal:  Am J Respir Cell Mol Biol       Date:  2015-01       Impact factor: 6.914

6.  Evolutionary demographic models reveal the strength of purifying selection on susceptibility alleles to late-onset diseases.

Authors:  Samuel Pavard; Christophe F D Coste
Journal:  Nat Ecol Evol       Date:  2021-01-04       Impact factor: 15.460

7.  Modulation of trinucleotide repeat instability by DNA polymerase β polymorphic variant R137Q.

Authors:  Yaou Ren; Yanhao Lai; Eduardo E Laverde; Ruipeng Lei; Hayley L Rein; Yuan Liu
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

8.  Molecular insights into the OGG1 gene, a cancer risk modifier in BRCA1 and BRCA2 mutations carriers.

Authors:  Carlos Benitez-Buelga; Tereza Vaclová; Sofia Ferreira; Miguel Urioste; Lucia Inglada-Perez; Nora Soberón; Maria A Blasco; Ana Osorio; Javier Benitez
Journal:  Oncotarget       Date:  2016-05-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.